Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Euronext Paris  >  Pharmagest Interactive    PHA   FR0012882389

PHARMAGEST INTERACTIVE

(PHA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsAnalyst Recommendations

PHARMAGEST INTERACTIVE : Ex-dividend day for final dividend

share with twitter share with LinkedIn share with facebook
share via e-mail
0
07/01/2019 EST

A final dividend is removed today from Pharmagest Interactive's share.



© Factset 2019
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on PHARMAGEST INTERACTIVE
2019PHARMAGEST INTERACTIVE : 3rd quarter earnings
CO
2019PHARMAGEST INTERACTIVE : Group wins the top prize in its category of the 2019 GA..
PU
2019PHARMAGEST INTERACTIVE : MALTA INFORMATIQUE expands the coverage of its services..
PU
2019PHARMAGEST ITALIA ACCELERATES ITS GE : acquisition of SVEMU
PU
2019PHARMAGEST INTERACTIVE : H1 2019 results
PU
2019PHARMAGEST INTERACTIVE : H1 2019 revenue
PU
2019PHARMAGEST INTERACTIVE : H1 2019 revenue
AQ
2019PHARMAGEST INTERACTIVE : 2nd quarter earnings
CO
2019PHARMAGEST INTERACTIVE : Ex-dividend day for final dividend
FA
2019PHARMAGEST INTERACTIVE : ANNUAL GENERAL MEETING - Notice
PU
More news
Financials (EUR)
Sales 2019 157 M
EBIT 2019 42,1 M
Net income 2019 28,6 M
Finance 2019 44,8 M
Yield 2019 1,42%
P/E ratio 2019 34,0x
P/E ratio 2020 29,5x
EV / Sales2019 5,96x
EV / Sales2020 5,36x
Capitalization 982 M
Chart PHARMAGEST INTERACTIVE
Duration : Period :
Pharmagest Interactive Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PHARMAGEST INTERACTIVE
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 2
Average target price 71,80  €
Last Close Price 65,40  €
Spread / Highest target 13,1%
Spread / Average Target 9,79%
Spread / Lowest Target 6,42%
EPS Revisions
Managers
NameTitle
Dominique Pautrat Chief Executive Officer, Director & Head-Pharmacy
Thierry Chapusot Chairman & Investor Relations Contact
Denis Serge Claude Supplisson Chief Operating Officer, Deputy GM& Director
Jean-Yves Samson Chief Financial Officer & Head-Investor Relations
Damien Maringer Technical Director-Research & Development
Sector and Competitors
1st jan.Capitalization (M$)
PHARMAGEST INTERACTIVE7.92%1 089
ORACLE CORPORATION4.62%176 036
SAP AG4.69%162 697
INTUIT7.99%70 980
SERVICENOW, INC.10.70%56 851
CONSTELLATION SOFTWARE INC.7.04%21 934